Committee Testimony and Witness Signup
SB0441 - Maryland Medical Assistance Program - Prescription Digital Therapeutics
Finance 2/28/2023 1:00:00 PM
As of: 12/3/2024 2:13:03 PM
| Name | Organization | Position | Testimony | Committee |
|---|---|---|---|---|
| Senator Lam, Senator Lam | FAV |
In Person - Oral Testimony |
FIN | |
| Whetsell, Scott | Maryland-DC Society of Addiction Medicine | FAV | MDDCSAM - 2023 SB 441 FAV - Prescription Digital T | FIN |
| Rosen-Cohen, Nancy | NCADD-Maryland | FAV | NCADD-MD - 2023 SB 441 FAV - Digital Therapeutics | FIN |
| Brocato, Deborah | UNF |
In Person - Oral Testimony 2023 SB441 Written Testimony.pdf MD SBHC Reproductive Health Standards (1).pdf |
FIN | |
| Martin, Dan | Mental Health Association of Maryland | FAV |
In Person - Oral Testimony SB0441 digital therapeutics.pdf |
FIN |
| Plante, Cecilia | Maryland Legislative Coalition | FAV | No Testimony | FIN |
| Obasiolu, Favour | Public Policy Partners | FAV |
In Person - Oral Testimony |
FIN |
| Grollmes, Joshua | MATOD | FAV | MATOD - 2023 SB 441 FAV - Digital Therapeutics - S | FIN |
| Elalamy, Sara | Digital Therapeutics Alliance | FAV |
In Person - Oral Testimony DTA- SB0441 Testimony .docx.pdf |
FIN |
| Wright, C. Vaile | American Psychological Association (APA) | FWA | 2023 MD SB 441 - APA DTx Testimony.pdf | FIN |
| Berman, Paul | Maryland Psychological Association | FWA |
Virtual - Oral Testimony MPA Testimony 2023 - Support with Amendments - Sen |
FIN |
| Shattuck, Daniel | Brocato & Shattuck | FWA |
In Person - Oral Testimony |
FIN |
| Gochenaur, Angela | Pear Therapeutics | FAV |
In Person - Oral Testimony Gochenaur FINAL Pear Written Testimony - Maryland |
FIN |
| Kim, Edward | Orexo US | FAV |
Virtual - Oral Testimony |
FIN |
| Lam, Clarence | FAV |
LAM_SB441_FAV.pdf
Lam_SB441_Slides.pdf |
FIN | |
| (MD), State of Maryland | UNF | 8 - SB 441 - FIN - MDH - LOC.pdf | FIN | |
| Krone, Christine | FAV | SB0441 FAV_MedCHI - PH - MD Med. Ass. Prog. - Pres | FIN | |
| Testimony, All | N/A | Merged Testimony as of 2-27-2023 at 322 PM | FIN |